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Les amours sont comme les champignons. On ne sait 
si elles appartiennent à la bonne ou à la mauvaise 
espèce que lorsqu'il est trop tard. 
Tristan Bernard 
Abstract 
 
Nowadays fungal pathogens are causal agents of various infections in the human body. 
Among this life threatening fungi, Candida albicans stands out due to high mortality 
worldwide. Especially for immunocompromised patients candiasis has turned out to be a 
serious health concern. Under normal physiological conditions they are innocuous inhabitants 
of the human’s normal flora, but only minimal variations from normal conditions can 
precipitate an attack.  
The widespread usage of antifungal therapeutics has lost efficacy because of the resistance 
that Candida albicans has developed by various mechanisms. The exposure of Candida 
albicans to antifungal drugs creates stress responses which activate parallel signal pathways. 
Two major pathways (PKC and Calcineurin p.) display a major contribution to Candida 
albicans’ barrier. Thereby the key regulators of these pathways (Hsp90, GSK3 and PKC) 
show a link between the transcriptional events which make Candida albicans invulnerable 
against therapeutic treatment. The investigation of different expressions of these key 
regulators confirms their presence in Candida albicans.  
An attractive inhibitor would have the capability to stop the cascade which contributes to the 
resistance of Candida. We expected this attribute from the group of bisindolylmaleimides 
which has already been described to have an effect on PKC. The inhibition of PKC by BisIII 
was studied in carcinogenic cells but still unknown in Candida albicans.  
The affinity micro assay should help to elucidate a possible interaction between PKCƞ and 
BisIII. Finally the affinity micro assay has confirmed an effect that BisIII exercises on 
Candida albicans’ mechanism of resistance by interfering with the PKC pathway.  
The knowledge about a possible interaction could be used as a starting point for further 
investigations with BisIII which may restore the sensitivity to azoles and furthermore increase 
the efficacy of the antifungal treatment. 
  
   
Zusammenfassung 
 
Zahlreiche Infektionen in unserem Körper werden heutzutage von Pilzen hervorgerufen. 
Unter einer großen Vielfalt verschiedener Pilzarten befindet sich Candida albicans, der als 
einer der Haupterreger gilt. Welweit wird er gefürchtet, da er sich durch eine hohe Todesrate 
auszeichnet. Besonders immunsuprimierte Patienten sind von der Candidose betroffen, in 
deren Körper sich der Erreger sehr schnell ausbreitet. Unter normalen physiologischen 
Bedingungen ist dieser Pilz ein harmloser Bewohner unserer Flora, doch minimale 
Abweichungen dieser Lebensverhältnisse können eine Infektion auslösen.  
Die herkömmlichen Behandlungen mit antimykotischen Therapeutika stoßen meist auf eine 
Blockade, da der Erreger ausgeklügelte Mechanismen entwickelt hat, um eine Resistenz 
aufzubauen. Die Behandlung von Candida albicans mit herkömmlichen Antimykotika 
induziert die Bildung von reaktiven Sauerstoffradikalen, welche parallel zahlreiche 
Signalwege aktivieren. Besonders der PKC- und Calcineurin Signalweg scheinen maßgeblich 
an Candida albicans Abwehrsystem beteiligt zu sein. Dabei treten die Schlüsselenzyme 
(Hsp90, PKC und GSK3) in den Vordergrund, die eine Reihe von Transkriptionen im Körper 
codieren. Die Erforschung der verschiedenen Proteinexpressionen dieses Hefepilzes bestätigte 
das Vorhandensein dieser Schlüsselenzyme. 
Nun musste ein passender Inhibitor gefunden werden, der diese Signaltransduktionskette zu 
unterbrechen vermochte. Von der Gruppe der Bisindolymaleimides war bereits bekannt, dass 
sie PKC angreifen und inhibieren. Jedoch wurden diese Studien nur mit krebsbefallenen 
menschlichen Zellen durchgeführt und nicht mit Candida albicans. Mit Hilfe der Micro-
Affinitäts-Studie wurden die Interaktionen zwischen PKCƞ und BisIII beobachtet, wobei sich 
die Tatsache zu bewahrheiten erschien , dass BisIII genau auf den PKC Signalweg wirkt.  
Diese Erkenntnis könnte nun als Ansatzpunkt für weitere Forschungen mit BisIII verwendet 
werden, um so die Resistenz von Candida albicans gegen Antimykotika effizient zu 
eliminieren und dabei den Erfolg einer antimykotischen Therapie zu erhöhen.  
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1 Introduction 
 
Fungal pathogens are a significant cause of human mortality worldwide, especially among 
immunocompromised individuals 
[29]
. They have designed an elegant repertoire of 
mechanisms to survive the cellular stress exerted by antifungal drugs 
[30]
. This fact turns them 
into a genuine risk for the human health.  
Among the different kinds of fungal pathogens Candida albicans represents one of the 
leading human fungal pathogens which is responsible for various hospital acquired infectious 
diseases with a mortality rate of 50% 
[1]
. 
 
1.1 Objectives of the research 
 
The potency of Candida albicans to establish a persistent resistance to antifungal drugs turns 
it into a serious menace for human health. Thus weakening its resistance to antifungal drugs 
poses an attractive target in the clinical development of an efficient treatment against this 
threat.  
One aim of the laboratory involves the discovery of an efficient alternative to affect this 
fungal pathogen regarding to stop their potential of developing resistance against the 
antifungal drugs. The ability of Candida albicans to establish a persistent infection is namely 
based on its cellular signals that regulate release of factors from target cells responsible for  
the replication of pathogen 
[25]
.
 
 
Thereby the studies are focused mainly on the PKC and Calcineurin transduction pathways. 
Both pathways are well known for regulating drug resistance turning the Candida cells 
invulnerable by various mechanisms. Important mediators (PKC, Hsp90 and GSK3) of the 
two pathways are studied since. As key mediators of stress response in Candida albicans they 
are implicated in various signal pathways. Inhibition of PKC, Hsp90 and GSK3 could be 
utilized as a novel mechanism of antifungal treatment. Moreover it can be used as a starting 
point to develop novel therapeutics which nowadays present a necessity due to increased drug 
resistance in clinical isolates.  
  Introduction 
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1.2 Working steps 
 
1. Validation of antibodies in Candida albicans 
The target was to study exactly the key regulators in these pathways, regarding to degrade 
their contribution to Candida albicans’ virulence. Therefore the different protein expressions 
in the eukaryotic model were investigated to get a better understanding of our target. The 
technique of Western blotting was used to gain insight in the inner life of Candida albicans. 
The proteins GSK3α, PKC and Hsp90 were focus of interest, assumed to play an important 
role in Candida’s transduction network. The incoming results have been validated using HeLa 
protein expressions as a reference. 
  
2. Affinity Micro Assay 
As a strong signal of each of these proteins was detectable, the research continued on the 
synthesized substance BisindolylmaleimideIII (BisIII) (synthesized by the group of IICiMED) 
from which we supposed that the mechanism of action in carcinogenic cells is related to its 
interaction with the key proteins in Candida albicans.  
The group of bisindolylmaleimides has been chosen which is a potent inhibitor of protein 
kinase C. But they are not entirely selective for PKC, known to inhibit a few other protein 
kinases in carcinogenic human cells 
[34]
. Furthermore they are capable of restoring sensitivity 
to azoles. So the effects of BisIII are ascertained on the key proteins in Candida albicans. 
  
3. Affinity Chromatography and Mass Spectrometry 
The affinity micro assay is chosen as the method to prepare the experiment for larger 
dimension like the affinity chromatography. It is more likely to assert the important 
parameters in micro dimension than working on larger scales. In the end it is only a 
preparative method for the affinity chromatography where the whole repertoire of interaction 
between the bisindolylmaleimides and Candida albicans’ proteins can be described. In 
common with the mass spectrometry, the affinity chromatography can give a notion of the 
extent of interplays that can occur between the bisindolylmaleimides and the fungal 
pathogens. 
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1.3 The opportunistic fungus-Candida albicans 
 
1.3.1 Model organism 
 
The polymorphic fungus Candida albicans is an outstanding eukaryotic model for studying 
cellular processes 
[23]
. Nowadays the prognosis of Candida albicans’ infection is hampered by 
the reduced efficacy of currently available drugs, the development of antifungal resistance and 
the lack of rapid and specific diagnostic tests 
[24]
. 
 
 
Figure 1. Candida albicans [GRAPHICSHUNT.com] 
 
1.3.2 The fungal skills 
 
Under normal physiologic conditions the opportunistic pathogen is an inactive component of 
human’s normal flora in the oral cavity, gastrointestinal tract and vaginal micro flora [22]. 
But only minimal variations from normal conditions could provoke the Candida attack. The 
fungus disseminates through blood and lymphatic and induces a strong inflammatory 
response, mostly in the target organs 
[31]
. Diseases due to Candida show a variety of clinical 
manifestations, ranging from mucutaneous infections of the mouth, esophagus, and vagina to 
life threatening systemic infections 
[28]
. 
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1.3.3 Combat of Candida infections 
 
Despite intensive drug discovery efforts, there are only five major classes of antifungal drugs, 
which combat fungal infection 
[28]
. Three of the five classes of antifungal drugs in clinical use 
target function or biosynthesis of ergosterol, the main sterol of fungal cell membrane. Thereby 
allylamines affect the squalen epoxidase, polyenes work against ergosterol and azoles attack 
the lanosterol demethylase. Despite their widespread usage the azoles are fungistatic rather 
than fungicidal. Working against the activity of 14α-demethylase, the antifungal treatment 
blocks the production of ergosterol, which results in an accumulation of toxic sterol 
intermediates 
[30]
. 
In contrast antimetabolites and echinocadins try to turn fungi vulnerable targeting the fungal 
nucleic acid or their cell wall (Figure 2).  
 
 
Figure 2. Antifungal drugs and their targets [ANDERSON, 2010] 
 
Classic mechanisms of getting rid of antifungal drugs, involve the over-expression of 
multidrug transporters that efflux azoles and mutations in Erg11 that causes Erg11 over-
expression. Lanosterol 14α-demethylase is encoded by Erg11 gene. These mechanisms 
prevent the azoles from inhibiting their target. Additionally, the close evolutionary 
relationship that fungi share with the human host aggravates the search of fungal selective 
drug targets 
[30]
. 
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1.3.4 Morphogenetic plasticity 
 
To achieve adaptability to a range of physiological extremes, the fungus has developed 
diverse mechanisms of sensing and responding to environmental challenges by activating 
developmental alterations that result in coordinated changes in cell physiology, morphology 
and adherence 
[42]
. Candida albicans’ virulence is intimately coupled with morphogenetic 
plasticity. It demonstrated its ability to switch between budding yeast form to a hyphal 
composed of filaments. This metamorphosis is implicated in virulence since the mutants 
defective in the yeast to filamentous transition are more attenuated in virulence 
[29]
. The 
dimorphic transition causes a change in immune response because of epitope change 
[31]
. 
The protein Hsp90 governs the key transition from yeast to filamentous growth in the absence 
of external elicitors by repressing Ras-PKA signalling. But Hsp90 capacity of orchestrating 
Candida albicans’ morphogenesis is mainly a response to temperature change, because it 
requires an elevated temperature of 37ºC 
[29]
.
 
 
 
1.3.5 Stress response network 
 
Increased ROS formation is a common consequence of many pathologies, including infection 
and inflammation. It provides a link between signaling pathways and transcriptional events 
that in turn regulate a large number of genes 
[32]
. 
 
Figure 3. Stress Response Network in Candida albicans [ANDERSON; 2010] 
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The exposure of Candida albicans to antifungal drugs creates stress responses, which are 
transduced through a variety of membrane receptors. The intensity of the signal transmission 
is basically dependent on the dose and the nature of the drug. As a result, parallel signaling 
pathways are activated in Candida albicans. One of the most important is the MAP-kinase 
signal transduction which induces the Mkc1 and Hog1p pathways. Hsp90, Calcineurin and 
PKC are important actors in this network and as stress response components they pose targets 
in the search of antifungal treatments
 [38]
. As a consequence they lead to an upregulation of 
glycerol- , glucan- , filamentation- , Hsp90- , glutathione- and SOD production (Figure 3). 
The deletion of these proteins would confer hypersensitivity to azoles 
[39]
. 
 
1.4 Signaling pathway in Candida albicans 
 
PKC, a serine/threonine kinase, governs a range of biological processes in Candida albicans. 
The cell wall integrity, morphogenesis, and 
also the response to cell wall stress undergo its 
regulation 
[1]
. The contribution of the PKC- and 
Calcineurin pathway to antifungal resistance 
are transduced through a variety of substrates. 
Signalling through Rlm1 regulates at least 25 
different genes, which are responsible for the 
cell wall biogenesis 
[46]
. Inhibiting the key 
regulators would stop the cascade (Figure 4). 
 
1.4.1 Architect of the fungal cell wall 
 
The cell wall represents a scaffold, an armour 
and an environmental gate. Fungal cell walls 
have a dynamic structure which consists of 
glycoproteins and polysaccharides that are able 
to withstand the cytoplasmic turgor pressure  
 
Figure 4. PKC- and Calcineurin Pathway 
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and external injuries. It acts as a mediator between the inner life and environment outside 
[36]
. 
Chitin represents an essential part of the fungal cell wall while CHS are promoters of 
transcriptional regulation of chitin synthesis. The regulation of both, CHS gene expressions as 
well as chitin synthesis are under the control of PKC, HOG MAP kinase and Ca
2+ 
Calcineurin 
signaling pathways 
[35]
.  
 
1.4.2  PKC isoforms 
 
Different isoforms of PKC are known and divided into three groups: the classical PKC 
isoforms α, βI, βII, γ (cPKC), and the novel PKC isoforms δ, ε, θ, η, μ (nPKC) and the 
atypical PKC isoforms λ and ζ (aPKC). The classical PKCs are characterized by four 
conserved domains named C1-C4. The C3 domain is responsible for ATP binding where 
bisindolylmaleimides are attracted to 
[44]
. 
 
 
Figure 5. Structure of PKC [WAY, CHOU, KING, 2000] 
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1.4.3 Heat Shock Protein 
 
Hsp90 is part of the group of the heat shock proteins that regulate the function of diverse 
client proteins in all eukaryotes 
[29]
. It uses a complex mechanism of ATP-ase coupled 
conformational changes to establish the possibility of interaction with a bride range of 
unstable or metastable proteins 
[39, 40]
. 
The function of Hsp90 is the enhancement of calcineurin dependent stress response, while 
interacting with it causes poisoning for activation. Calcineurin is considered as the key 
mediator of Hsp90 dependent azole resistance. Indeed Hsp90 and calcineurin are suspected to 
be one of the main factors causing resistance in Candida albicans 
[1]
. 
While Hsp90 regulates the calcineurin activity, it acts also as an agent between MAPK and 
Mkc1. Hsp90 stabilizes Mkc1 independently of its activation status and thereby regulates 
PKC signaling. Genetic depletion of Hsp90 ends in decreasing stability of C. albicans Mkc1, 
which indicates another functional connection between Hsp90 and PKC (Figure 4) 
[1]
. 
Hsp90 may influence evolution by releasing previously silent genetic variations in response to 
environmental change. The molecular chaperone pushes the development of drug resistance 
and enhances new mutations which have a visible effect on the phenotype.
 
It seems that 
Hsp90 might affect the evolution in two different ways. On one side Hsp90 can create, as a 
preserver of cryptic genetic variation, new traits. On the other side Hsp90 can control mutated 
cell regulators with an oncogenic potential. Thus Hsp90 may play an important role as a 
capacitor for the storage and release of genetic variations 
[37]
. 
 
1.4.4 GSK3 
 
GSK3 is a ubiquitously distributed serine threonine kinase encoded by two different genes, 
alpha (α) and beta (β) [27]. The protein GSK3 is implicated in multiple cellular processes and 
linked with the pathogenesis of several diseases which makes it attractive as a key target in 
drug discovery 
[28]
.
 
A calcineurin inhibitor can be seen as a potent killer of Candida albicans. 
The protein Rcn1 works on this base, then it binds Calcineurin and inhibits so its function 
(Figure 4). But the effect of Rcn1 is abolished by the intervention of GSK3. Upon the 
phosphorylation by GSK, Rcn1 is degraded and inhibited in its interaction with calcineurin 
[28]
. 
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1.5 Inhibitors of the eukaryotes-Bisindolylmaleimides 
 
The group of bisindolylmaleimides is originally isolated from the culture of Nacardiopsis. 
They target several other signaling molecules apart from PKC in mammalian cells 
[33]
.  
 
Targets of bisindolylmaleimides: 
  
 Inhibition of PKC and/or MDR activity 
 Modulation of Wnt signaling pathway 
 β-Catenin stabilization 
 Elimination of antiapoptotic elements (cFLIP) 
 Activation of intrinsic apoptotic pathways [33] 
 
The variety of targets of bisindolylmaleimides contributes to their possible potency to disable 
the resistance mechanism of Candida albicans. They could repress uncontrolled proliferation 
and restore the sensitivity to antifungal treatment. Bisindolylmaleimides are inhibitors of the 
catalytic domain, therefore directed either to the substrate site or to the ATP binding site. 
Their structure resembles the staurosporine indolocarbazole structure. Although the 
staurosporine are more potent, the bisindolylmaleimides show a greater selectivity for PKC 
isoforms 
[45]
. 
 
Figure 6. Structure of BisIII
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2 Protein preparation 
 
Many different proteins participate in the composition of a single cell. So the separation and 
isolation, or purification of proteins constitute an essential first step to further 
experimentation. Thereby it is important to avoid contamination to obtain a pure sample of the 
proteins of interest 
[41]
.  
 
2.1 Cell disruption 
 
The sample preparation for running on a gel implies the lysis of the cells to provoke the 
release of the proteins of interest. The cells are broken, releasing soluble proteins. This 
process also breaks many of the sub cellular organelles, such as mitochondria, peroxisomes, 
and endoplasmic reticulum 
[21]
. There are three main methods for release of intracellular 
proteins from microorganisms: enzymic, chemical or physical 
[41]
. Thereby diverse detergents, 
salts, and buffers could be used to encourage lysis of cells and to solubilize proteins. A 
protease inhibitor cocktail is often added to prevent the digestion of the sample by its own 
enzymes. The whole tissue preparation should be carried out at cold temperatures (4°C) to 
avoid protein denaturing and degradation.  
 
2.2 Materials 
 
 Bicinchoninic Acid Protein Assay Kit, SIGMA-ALDRICH 
 Sterile Nuclon Surface- 96 well-plate, SIGMA-ALDRICH 
 DensiCHECKTM plus, bio-Merieux 
 Shaking Incubator SI500, stuart 
 Centrifuge 5417C/R, Eppendorf 
 Centrifuge BR 4i, Jovan 
 MM400 MixerMill, Retsch 
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2.3 Candida cultivation 
 
To assure a strict sterile condition in order to handle with cells, it was necessary to work 
under the laminar air flow. CA98001 cells were applied with a loop on the culture ground 
(Sabouraud Gentamicin Chloramphenicol 2-Agar) in a test tube, so that they could grow fast 
to a visible culture after 24h incubation at 37ºC. An inoculum from the grown Candida 
albicans culture was taken and immerged in a new YPD
8
 medium. After an overnight stay in 
a shaking incubator at a temperature of 30ºC the amount of cells was sufficient for the 
following protein extraction.  
 
2.3.1 Candida extraction 
 
The nutrient medium containing the Candida cells was divided equally into two Falcon tubes. 
The tubes of 50ml were centrifuged for 5min at 3500 rpm at 4ºC. Only the obtained pellets 
were kept.  
The first Falcon tube was treated with 10ml PBS 1X to transfer the liquid afterwards into the 
second Falcon tube. For this reason, only the second tube was centrifuged again for 5min at 
3500rpm at 4ºC. The liquid was poured away and replaced by 10ml PBS 1X. Aliquots of 
250µl were created in Eppendorf tubes (2ml), which were centrifuged for 5min at 5000rpm at 
4ºC, thus the formed pellets were frozen quickly in liquid nitrogen. Thereupon 5 glass 
marbles were added to each tube before crushing cells for 6min at high speed. After the 
crushing an extraction buffer
11
 containing M-PER, an Anti protease cocktail (PIC:M-
PER…1:1000) and PMSF (PMSF:M-PER…1:100) was added, whereupon the chosen 
concentration depended on the volume of the pellet, and placed for a further centrifugation at 
5000rpm in the apparatuses. 
The supernatants were collected in one tube to separate them afterwards into aliquots of 300µl 
which were stored at -80ºC. 
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2.4 Recuperation of Henrietta Lack’s Cells (HeLa) 
 
The HeLa cells were cultivated on the nutrient media RPMI (+10% FBS) in a 75ml flask. 
Before all, RPMI media had to be eliminated with a bulb pipette under the flue and the culture 
flask was washed with enough PBS 1X (stored at 4ºC) and removed afterwards. 6ml of the 
PBS 1X were used to cover the protein ground. By using a scrapper the cells were collected 
while the cell flask remained on ice. The liquid containing PBS and cells was taken before 
another washing with PBS 1X. All the PBS containing the cells was collected accurately in a 
test tube, which was centrifuged at 15000rpm for 10min at 4ºC afterwards. The formed pellet 
was kept while getting rid of the PBS 1X. 1ml extraction buffer
11
 was added to each 100µl of 
wet cell pellet. The mix was prepared in a tube and vortexed. The pellets were well washed 
with the extraction buffer. The tube containing the pellet was placed at 4ºC for half an hour 
and then centrifuged at 15000rpm at 4ºC. Aliquots were created and kept at -80ºC. 
 
2.5 Protein quantification 
 
To work in a reproducible way, it was necessary to quantify the amount of proteins that had 
been extracted. Although many assays are suited, the bicinchoninic acid protein assay kit 
(BCA) was chosen to check the proteins concentration of the cell-lysates. 
 
2.5.1 Bicinchoninic Acid Protein Assay Kit  
 
The principle of the bicinchoninic acid (BCA) assay is similar to the Lowry procedure, 
because both rely on the formation of a Cu
2+
 protein complex under alkaline conditions, 
followed by the reduction of the Cu
2+
 to Cu
1+
 
[5]
. The amount of reduction is proportional to 
the proteins present. It has been proved that cysteine, cystine, tryptophan, tyrosine, and the 
peptide bond are able to reduce Cu
2+
 to Cu
1+
 
[6]
. BCA forms a purple-blue complex with Cu
1+
 
in alkine environment, thus providing a basis to monitor the reduction of alkaline Cu
2+
 by 
proteins 
[7]
. 
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2.5.2  Working Procedure 
 
At the beginning BSA protein standards of different concentrations have to be prepared. This 
is accomplished by making serial dilutions. 
 
200µl of the BCA working reagent (containing Cooper Solution and acid solution in a ratio 
1:50) are applied to 10µl and 15µl BSA protein standard and cell-lysate samples on a 96-well 
plate followed by an incubation for 30 min at 37ºC. The cell-lysates are previously diluted to 
achieve a more reproducible result. 
 
 
 
 
 
BSA  Protein Standards 
C
el
l-
ly
sa
te
s 1:5 
1:10 
15µl 
10µl 
   A         B        C         D        E          F         G   
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The absorbance of the solution was measured at 570nm. Thereby the absorbance of the 
samples was compared to the standard curve so that the concentration of the unknown 
samples could be determined. 
 
 
 
BSA 
(reference) 
OD 
C 
(µg/ml) 
A 1,209 2000 
B 1,022 1500 
C 0,77 1000 
D 0,647 750 
E 0,483 500 
F 0,351 250 
G 0,190 0 
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3 Immunodetection of Candida albicans’ signal 
proteins  
3.1  Methods  
3.1.1 Western Blotting 
 
Immunoblotting or Western blotting is met with success as the technique, where proteins are 
transferred from an electrophoresis gel to a support membrane and probed with antibodies 
[4]
.
 
It is a powerful tool to detect and characterize a multitude of proteins.  
The transferred proteins are immobilized on the surface of the membrane in a manner that is 
an exact replica of the gel. Unoccupied protein-binding sites on the membrane are saturated to 
prevent non specific binding of antibodies 
[4]
. The blot is probed first with a specific primary 
antibody. Then the blot is probed a second time. The second probe is an antibody that is 
specific for the primary antibody type and is in addition conjugated to a detectable enzyme. 
The site of the protein of interest is thus tagged with an enzyme through the specifities of both 
antibodies 
[4]
. 
 
3.1.2 Gel electrophoresis 
 
“The popularity of gel electrophoresis is based on its high resolving power, its ability to 
analyze many samples simultaneously, the micrograms amount of proteins that it requires, the 
possibility it offers to recover the proteins after electrophoresis, and the modest cost of the 
method 
[19].” 
 
Gel electrophoresis can provide information about the molecular weights and charge of 
proteins, the subunit structures of proteins and the purity of a particular protein preparation. It 
is relatively simple to use and it is highly reproducible. Polypeptides differing in molecular 
weight by as little as a few hundreds of Daltons and proteins differing by less than 0.1 pH unit 
in their isoelectrical points are routinely resolved in gels
 [4]
. 
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3.1.3 SDS Page [4]  
 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is the most 
commonly practiced gel electrophoresis technique used for proteins. It requires the 
denaturation of proteins to their consistent polypeptide chains.
 
 
When SDS is used with proteins, all of the proteins become negatively charged by their 
attachment to the SDS anions. SDS denatures proteins by wrapping around the polypeptide 
backbone and SDS binds to protein fairly specifically in a mass ratio 1:4:1.
 
It is usually 
necessary to reduce disulphite bridges in proteins before they adopt the random-coil 
configuration necessary for separation by size by using β-mercaptoethanol or dithiothreitol 
(DTT).  In denaturizing SDS-PAGE separation, migration is determined not by intrinsic 
electrical charge of the polypeptide, but by molecular weight. 
Buffers supply current carrying ions, maintain desired pH and provide a medium for heat 
dissipation. Continuous systems use the same buffer at constant pH, in the gel, sample, and 
electrode tanks. With continuous systems, the sample is loaded directly on the gel in which 
separation will occur. 
 
3.1.4 Polyacrylamide-gels 
 
Polyacrylamide-gels are formed from the polymerization of two compounds, acrylamide and 
N, N-methylene bisacrylamide (Bis). Bis is a cross-linking agent for the gels. The 
polymerization is initiated by addition of ammonium persulfate along with either DMAP or 
TEMED. The gels are neutral, hydrophilic, three dimensional networks of long hydrocarbons, 
crosslinked by methylene groups. The separation of molecules within a gel is determined by 
the relative size of the pores formed within the gel. The pore size of a gel is determined by 
two factors, the total amount of acrylamide present and the amount of cross linker. As the 
total amount of acrylamide increases, the pore decreases.  
 
The smaller the size of the protein of interest is, the higher is the percentage of mono/bis. The 
bigger is the size of the protein of interest is, the lower is the percentage of mono/bis.  
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Protein size (kDa) Gel percentage (%) 
4-40 20 
12-45 15 
10-70 12,5 
15-100 10 
25-200 8 
 
3.2 Materials 
 
 Block Heater, Grant 
 Mini Protean® Comb, BIO-RAD 
 Mini Protean Tetra System, BIO-RAD 
 Power Pac-Basic, BIO-RAD 
 Minipulse3, Gilson 
 Yellow Squid Magnetic stirrer, IKA 
 Optitran reinforced Nitrocellulose Transfer Membranes-45µm, Whatmann 
 Trans Blot SD/ Semi-dry Transfer Cell, BIO-RAD 
 Mini Protean 3-Cell Serial No 675, BIO-RAD 
 Extra Thick-Blot Paper, xi size, BIO-RAD 
 Gyro Rocker SSL3, Stuart 
 Labroller Rotator, Labnet 
 Minilab Roller Rotator, Labnet 
 G Box, Syngene 
 
3.3 Working Conditions 
 
A continuous buffer-, denaturing-, one dimensional- SDS gel was considered as the best way 
to let the proteins migrate. 
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First of all the running gel solution had to be prepared. Since the concentration of the 
acrylamide gel influences the running condition, the percentages of 12% and 15% acrylamide 
were chosen. The gel volume had to be determined by calculation or measuring the amount of 
acrylamide gel needed to fill a cassette.  
 
 Gel 
6% 
Gel 
10% 
Gel 
12% 
Gel 
15% 
H20 8ml 5,9ml 5ml 3,5ml 
30% Acrylamide-mix 3ml 5ml 6ml 7,5ml 
1,5M Tris HCl (pH=8,8) 3,8ml 3,8ml 3,8ml 3,8ml 
10% SDS 0,15ml 0,15ml 0,15ml 0,15ml 
10% APS 0,15ml 0,15ml 0,15ml 0,15ml 
TEMED 0,012ml 0,006ml 0,006ml 0,006ml 
 
The components were mixed together and after adding TEMED and APS the gel would 
polymerize fairly quickly. Therefore, the transfer of the solution to the gel cassette should be 
carried out as fast as possible. 
 
Before applying the acrylamide between the glass plates of the gel electrophoresis instrument, 
the apparatus should be assembled together. Ethanol was added to assure an uniform surface 
and then the gel was allowed to polymerize for about 20 min. After the polymerization the 
components of the stacking gel
10
 were prepared. The solution was swirled gently and 
transferred to the top of the resolving gels using a pipette and bulb, after having eliminated the 
ethanol. Then the combs were aligned to its proper position by being careful not to trap 
bubbles under the teeth. The gel was allowed to polymerize for another 15min. 
Electrophoresis cells are essentially plastic boxes with anode and cathode buffer 
compartments, electrodes, and jacks for making electrical contact with the electrodes. Gels are 
held vertically between the electrode chambers during the run. The bottom is sealed with a 
gasket during gel formation and the top is open to receive monomer solution. The top and 
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bottom ends are open and in contact with buffer for electrophoresis. High voltage direct 
current supplies provide electrical power for electrophoresis
 [4]
. 
 
Meanwhile the protein samples are prepared after the following table: 
 
Tube Celltype Treated 
 with 
Nber of 
 depots 
Final 
Volume 
[µl] 
LB4X 
 
[µl] 
Prot 
Sample 
[µl] 
H20 
 
[µl] 
1 HeLa  MPER 2 60 15 25,27 19,73 
2 Candida  MPER 2 60 15 22,33 22,67 
 
For an experiment the protein concentration of each celltype should account 40µg, which was 
calculated on the basis of the results obtained after the protein quantification. 
In each tube the proteins LB4X
2
 and H2O were mixed together and vortexed afterwards. The 
samples were heated at 95ºC for 5min in a temperature block. Then they were centrifuged 
with 3000rpm for 3min at 4ºC. 
Afterwards the rest of the electrophoresis apparatus was assembled together and as soon as 
the polymerization was finished, the combs were removed carefully and the gel assembly was 
placed into the buffer tank. The reservoir was then ready to be filled with migration buffer
11
 
before the samples were loaded carefully in the wells of the gels with a pipette. The tank was 
closed with the lid and connected to the power supply. The power supply was turned on and 
set for following electrical conditions: 100V for 1h, and then increased slowly at 130V for 
50min.  
By the time the migration of a 15% gel was set up, the apparatus was placed onto ice to 
provide optimal conditions. The run was then proceeded until the blue tracking dye from the 
sample buffer reached the end of the gel. At the end of the run the gel was removed, ready to 
be transferred.  
 
3.4 Gradient Gel 
 
During electrophoresis in gradient gels, proteins migrate until the decreasing pore size inhibits 
further process. The main advantages of gradient gels outclass linear gels: 
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1. The line of the migration protein zone is retarded more than the trailing line, thus 
resulting in a sharpening of proteins bands. 
2. The gradient in pore size increases the regions of molecular weights that can be 
fractionated in a single run. 
3. Proteins with close molecular weights are more likely to separate in a gradient gel than 
in a linear gel [9]. 
 
The usual limits of gradient gels are 3-30% acrylamide in linear or concave gradients. The 
choice of range depends on the size of proteins being fractionated 
[9]
.
 
The gradient gel advanced the resolution of our membranes in an unexpected way. Before 
preparing a gradient gel, the choice of the percentage had been taken. We went for the 
acrylamid percentage from 6%-15%. So firstly the high percentage polyacrylamide solution 
(15%) was loaded into the first chamber (B) of the gradient maker. The low percentage 
polyacrylamide solution (6%) was rapidly loaded afterwards into the second chamber (A) 
(Figure 7).  
 
 
Figure 7. Gradient gel apparatus [WALKER, 1994] 
 
 
The flow on the pump was initiated (25rad/min); simultaneously the magnetic stirrer was 
turned on. The second chamber was opened after the high percentage of the polyacrylamide 
solution made 1cm of the gel. The pump is stopped when the solution was approximately 3 to 
4cm from the top of the glass plate. After adding the stacking, the gradient gel was ready for 
the migration. 
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3.5 Transfer 
Electro transfer from a gel to a membrane is done by directing an electric field across the 
thickness of the gel to drive proteins out of the gel and onto the membrane. Generally 
electrophoretic methods assure the recovery of the targeted proteins at high purity 
[4]
. 
 
3.5.1 Semi-dry blotting/Wet blotting 
 
In semi-dry blotting, the gel and membrane are sandwiched horizontally between two stacks 
of buffered wetted filter papers in direct contact with two closely spaced solid plate 
electrodes. The close spacing of the semi-dry apparatus provides strengths for high fields. The 
term semi-dry refers to the amount of buffer that is confined to the stacks of filter paper. 
Under semi-dry electro transfer conditions, some low molecular weight proteins are driven 
trough the membranes 
[4]
. 
The structure of a wet blot takes place according to the sandwich procedure, although the 
important filling is not jammed between two slices of bread, but two plastic grids of a gel 
cassette. 
[10]
. 
 
3.5.2 Membrane 
 
The most common membranes are constituted by nitrocellulose and PVDF. We worked only 
with nitrocellulose since the proteins are more likely to be on this kind of membrane. 
Nitrocellulose membranes are available in different pore sizes. The correct pore size depends 
on the size of the protein to be blotted. The blotting success for smaller proteins deteriorates 
with increasing pore size 
[10]
.We used a nitrocellulose membrane with a pore size of 45µm. 
The capacity of nitrocellulose to bind and retain proteins ranges from 80µg/cm
2
 to 
250µg/cm
2
, depending on the protein. Proteins bind to the nitrocellulose chiefly by 
hydrophobic interactions, although hydrogen bonding between amino acid side chains and the 
nitro group of the membrane may also be involved 
[11]
. In most cases it makes no difference 
which blotting procedure is used. The advantages of a wet blot lie in the gentler transfer and 
the lower heat that is thus applied to the protein. The disadvantages are higher expenditure of 
time and the larger amount of transfer buffer that is needed for the wet transfer 
[10]
. 
Immunodetection 
 
 
32 
 
  
The selected blotting membrane, as well as six to eight filter papers (Whatmann Paper) had to 
be cut to gel size. This should be done fairly accurately, since overhanging filter papers and 
edges of membranes could cause a short circuit during blotting 
[10]
. 
 
3.5.3 Transfer-conditions of Candida albicans’ proteins 
 
After the migration, the stacking gel was removed and the running gel was placed into 
transfer buffer
5, 9
 for 20min. Meanwhile the nitrocellulose membrane was cut to the size of the 
gel (8x6cm) and immersed in the transfer buffer for 15min whereas the Whatman filter was 
only dipped into it. Then the transfer sandwich was assembled. A roller was used to roll over 
the sandwich gently to remove trapped air bubbles.  
 
 
Figure 8. Gel/Filter Sandwich [ROSENBERG,2006]  
 
In the classic transfer the gel/filter sandwich was put into the holder, so that the proteins could 
migrate from the gel to the membrane, in the direction of the positive electrode (anode). The 
whole apparatus was filled with the transfer buffer
5
 and put on ice.  
But the semidry transfer worked without filling a tank with buffer, placing the sandwich 
directly in the apparatus, only applying a few milliliters transfer buffer
9
 on top of the 
sandwich to avoid drying out during membrane transfer.The transfer duration depended on the 
proteins which were going to be detected in the next step. 
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Timetable: 
 
Transfer time-Semidry Transfer time-Classic 
 
1h….…10V  +  15min…….13V 
 
2h…….25V 
 
The greater the mass of the protein the more time was needed for the transfer, so the whole 
time was utilized when PKCƞ, Hsp90 and GSK3α were going to be detected later. In contrast 
the transfer time was reduced when the attention was turned to the Histones.  
 
3.6 Ponceau S 
 
Ponceau S (PS) is a negative stain that binds to the positively charged amino groups of the 
proteins. It also binds to non-polar regions in the protein 
[16]
. Protein binding by this stain is 
readily reversible by raising the pH 
[17]
. Ponceau S staining of blots can sometimes produce 
high background in the subsequent blot. This method of reversible staining of the blot gives a 
confidence that the migration was good and that the transfer was uniform across the 
membrane 
[15]
. But the detection limit is 250ng/ml. The red color of stained proteins is 
difficult to photograph and the stain fades with time 
[17]
. 
 
 
Figure 9. Ponceau S coloration  
 
Before applying Ponceau S, the membrane was washed with PBST. A small plastic box was 
used for the incubation with the Ponceau Solution
7
. After two minutes small protein bands 
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were observable as the Ponceau S had attached to the proteins. To decolorate the membrane, it 
was again washed with PBST while gentle agitating on a shaking platform. 
 
3.7 The role of Coomassie Brilliant Blue 
 
It is more common to make protein bands in gel visible by staining them with dyes or metals. 
Each type of protein stain has its own characteristics and limitations regarding the sensitivity 
of detection and the types of proteins that take up the stain best 
[4]
. Coomassie Brilliant Blue is 
the standard stain for protein detection in polyacrylamide gels. They need only to be covered 
with stain 
[4]
. It is sensitive approximately down to 20µg protein per ml. 
 
Figure 10. Gradient gel (6%-15%) after Coomassie Brilliant Blue Staining 
 
Coomassie Brilliant Blue is an aminotriarylmethane dye that forms strong but not covalent 
complexes with proteins, most probably by a combination of Van der Waals forces and 
electrostatic interactions with NH3
+
 groups. The uptake of dye is approximately proportional 
to the amount of proteins, following the Beer-Lambert law 
[14]. Coomasssie Brilliant Blue R-
250 is more soluble than the G-250 variety. In acidic solution it doesn’t form colloidal 
particles that are too large to penetrate surface gel pores
 [4]
. 
After the transfer the gel was immersed in at least 5ml staining solution
4
 containing 
Coomassie Brilliant Blue R-250 and placed in a small plastic box on a slowly shaking 
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platform for 1h at room temperature. The stain was removed and saved for future use. The gel 
was destained without the dye by soaking it in an ethanol/acetic acid solution
3
 on the shaker 
overnight, changing the destaining solution three or four times.  
 
3.8 Blocking 
 
Since not only proteins from the gel bind to the membrane but other proteins (e.g. detection 
antibodies) like to settle there as well, before the beginning of the actual detection reaction it 
is absolutely necessary to block the nonspecific protein binding sites. This happens through 
incubating the membrane with irrelevant proteins, which cover the non specific binding sites 
(block), so that the detection is reduced, and thus the sensitivity of the Western Blot is 
increased 
[10]
. To minimize the loss of weakly bound proteins during blocking, a whole range 
of different solutions is available. Different variations of protein solutions (cattle serum 
albumin, horse serum) or anionic detergents (Tween 20) are often used 
[4]
. 
Sometimes they are mixed. The second purpose is less known and perhaps even less 
understood, but blocking membrane can promote renaturation of antigenic sites 
[15]
. 
Nonetheless it is crucial that the solution doesn’t disturb the subsequent detection reaction.  
 
Working conditions 
The membrane was blocked in either 5% BSA in TBST or 5% Milk in TBST, placed on the 
shaker for at least 30 min, preferably 1-2h at room temperature. Meanwhile the primary 
antibody could be already prepared. 
 
3.9 Detection 
[10]
 
 
The actual detection of the relevant protein on the membrane is reached by staining of 
antibodies. A suitable specific antibody serves as the tool for the immune detection. 
Appropriate primary antibodies can be produced in any convenient animals, such as rabbits or 
mice or goat . 
After the binding of an antigen- specific, unlabelled primary antibody, detection with a 
second, species specific, labeled antibody called secondary antibody happens. It binds to the 
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constant part of the primary antibody that is bound to the protein. Enzymes, fluorescent dyes, 
or even radioactive markers can be coupled to this secondary antibody. It does have 
advantages compared to direct staining, in which the primary antibody is conjugated directly 
with the detection reagent. The fact that several secondary antibodies can simultaneously bind 
to the constant part of the primary antibody results in an amplification effect which increases 
the sensitivity .The detection reagent that is conjugated to the secondary antibody determines 
the type of visualization of the antibody binding to the protein. The most common secondary 
antibodies used in Western blotting are alkaline phosphatase and horseradish peroxydase. The 
coupled enzymes of alkaline phosphatase or horseradish peroxidase catalyze the conversion of 
an appropriately added substrate to a colored or luminescent product in the detection reaction. 
An advantage of this is that the enzyme can convert many substrate molecules, which results 
in an amplification of the signal . 
Because the antigen is immobilized on a sheet, the antibody is not required to form a 
precipitate with the antigen. The blotting technique therefore has the potential for 
immunoelectrophoretic analysis of proteins by using binding of Fab fragments or binding of 
antibodies against a single determinant, such as monoclonal antibodies produced by 
hybridomas 
[6]
. 
 
3.9.1 Luminol Reaction 
 
Chemiluminescent substrates for horseradish 
peroxidase are based on oxidation of luminol.  The 
luminol substrate provides the most sensitive 
signal of the blotting substrates but requires 
photographic exposures or specially configured 
imaging devices 
[4]
. The principle is that when a 
substrate such as 5-amino 2,3 dihydro-1,4-
phthalazinedione (luminol) is oxidized by 
hydrogen peroxide, light is released during the 
chemical reaction. The substrate is thus a limiting 
reagent and light production ends as the substrate is 
oxidized
 [15]
.  Figure 11. Visualization Reaction 
[MACPHEE, 2010] 
Immunodetection 
 
 
37 
 
  
3.9.2 Polyclonal vs. monoclonal 
Both monoclonal and polyclonal antisera can be utilized for Western blot analyses. There are 
advantages and disadvantages in using either type. 
An advantage of polyclonal antisera is that it can possess many antibodies that are able to 
detect the protein of interest. It results generally in an enhanced signal. In contrast, a major 
disadvantage is that it can contain antibody molecules that can bind specifically to proteins 
unrelated to the protein of interest.
 
This effect can be explained by their way of production. 
Indeed they are obtained by immunizing animals with a synthetic peptide derived from the 
sequence of the Human protein. The unspecific interaction can be abolished by affinity 
purification 
[15]
.  
Monoclonal antisera provide by their design which is directed against one epitope, an elegant 
tool for identifying a particular region of the antigen 
[18]
.
 
One particular disadvantage can 
arise, if the specific antigenic site is significantly affected (i.e. denatured) by electrophoresis 
conditions, thus limiting or preventing antisera interaction 
[15]
. 
The most important ability that an antibody must have to work successfully in an immunoblot 
is to recognize denaturation-resistant epitopes. The epitopes that are displayed on the 
membrane will almost exclusively be those that are formed by linear stretches or amino acid 
modifications. These are the types of epitopes that remain intact following gel electrophoresis 
and transfer to the membrane support 
[18]
. 
 
3.9.3 Whole Sera 
 
Because polyclonal antibodies normally are used as whole sera, they also contain an entire 
repertoire of circulating antibodies found in the immunized animal at the time they were 
collected. Whole sera contain a wide range of antibodies that comprise the entire repertoire of 
antibody response presented in the animal at the time of serum harvest. This may include any 
auto antibodies against cellular components and antibodies against microorganisms that have 
infected the host animal, either at the time of collection or at any recent time, that have left 
circulating antibodies, or other antigens that are contaminating the immunizing preparation. 
These antibodies bind to the cognate, or any closely related, antigens on the blot, generating 
additional bands and potentially obscuring the bands of interest. Therefore, the serum may 
contain antibodies that specifically recognize spurious antigens 
[18]
. 
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Indeed the problem of whole polyclonal antibody sera can also be solved by affinity 
purification. 
 
3.9.4 Titrate 
 
The spurious bands caused by the unspecific antibodies in whole sera can be lessened by 
using the antibody at much lower concentrations. Then the immune antibodies have the 
highest concentration in serum, and thus titrating can lower the levels of the contaminating 
antibodies to levels that will not interfere with the analysis. Therefore dilution can be used to 
reduce nonspecific background problems without reducing sensitivity 
[18]
.  
 
3.10 Visualization 
 
The blot was soaked in a tray containing 50ml of blocking buffer (2,5g BSA dissolved in 
50ml TBST) for 30min at room temperature while shaking. Afterwards the blocked 
membrane was incubated with 5ml of the primary antibody of interest on a rotating scroller at 
4ºC overnight.  
 
 
The next day the membrane was washed with TBST, the first time 15min and then 3 times for 
5 min while gently agitating at room temperature. Then the incubation followed with the 
secondary antibody (Anti-rabbit IgG, HRP-linked Antibody) for 1h at room temperature and 
for another hour at 4ºC. Before visualization with the G-Box, the blot was again washed with 
TBST (1*15min, 3*15min). Then the immunoblots were incubated with a solution called 
Super Signal West Pico Chemiluminescent Substrate. Therefore two different solutions were 
Primary Antibodies 
PKCƞ-Antibody rabbit polyclonal whole sera 
Hsp90-Antibody rabbit polyclonal purified 
Gsk30-Antibody rabbit polyclonal purified 
HistoneH3-Antibody rabbit polyclonal purified 
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mixed equally together (SuperSignal West Pico Stable Peroxide Solution/ SuperSignal West 
Pico Luminol Enhancer Solution).   
The mix was used to incubate the membrane for 5min. The apparatus G-Box took pictures of 
the picochemiluminescent signals on the membrane.  
 
3.11   Stripping 
 
The practice of stripping immunoblots and reprobing provides the detection of multiple 
proteins on the same blot. This is a good method to examine two antigens under identical 
conditions 
[18]
. 
The important step that must be undertaken with any reagent to ensure proper “erasure”, is to 
re-incubate the stripped blot in substrate and expose to film to ensure no protein detection 
occurs as a result of remaining antisera. Then the blots can be washed and archived or 
reblocked for additional blot analyses 
[15]
. The bonds that hold antigens to nitrocellulose 
membranes are noncovalent, and all methods to strip the antibodies from the antigens also 
remove some of the polypeptides from the filter. Therefore this method is never quantitative.  
 
 
 
Figure 12. G-BOX 
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Practical Parameters 
 
The possibility to reuse the membrane with the stripping method shortened the working time. 
We were able to utilize the same membrane with different antibodies. Therefore the stripping  
solution had been heated on a magnetic stirrer. The membranes were incubated in the hot 
stripping solution for 30min and neutralized afterwards with Tris-buffer for another half an 
hour. Before blocking, they were washed with TBST as usual. 
Now the wished proteins could be detected after incubation with the primary and secondary 
antibodies. 
 
 
3.12   Antibody validation for Candida albicans 
 
The first step to get a better understanding of Candida albicans’ pathogenicity was to clear up 
their different protein expression since they have a contribution to the resistance of Candida 
albicans to antifungal treatment. The first step to investigate their influence implied their 
ways of expression, which we compared with the proteins of HeLa. The Hela proteins were 
just used as a reference.  
 
3.12.1   Different ways of detection of the PKCƞ signal 
 
Before we could use the proteins for the Western Blotting, they had to be extracted and 
prepared in the right way. The fragile work with the Candida albicans’ cells led to different 
results. We accorded the right choice of lysis buffer to have a major contribution to the 
different results. A difference between the used MPER- and Chilov-lysis buffer efficacy could 
be distinguished because the signals of Chilov treated proteins were paler. The first two 
signals of Ca/MPER and Ca/Chilov were not even visible. The results showed that the chosen 
lysis buffer has finally an effect on the results. The lysis buffer MPER worked significantly 
better than the lysis buffer Chilov with which we treated our cells at the protein extraction 
step.  
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Figure 13.1. PKCƞ spot lightning after migration on a 12% acrylamide gel. 1. Candida alb. treated 
with MPER, 2. Candida alb. treated with Chilov, 3. Candida alb. treated with MPER and Chilov, 4. 
Second Candida alb. culture treated with MPER, 5. Second Candida alb. culture treated with Chilov, 
6. Second Candida alb culture treated with Chilov and MPER, 7. HeLa treated with MPER, 8. HeLa 
treated with Chilov, 9. HeLa treated with MPER and Chilov 
This time the proteins had migrated on a 12% gel and were transferred then on the 
nitrocellulose membrane by the semidry method. The signal of PKCƞ had a long time coming 
on this picture since an admissible signal was remarkable after half an hour. The signals of 
Candida albicans are lower than the human HeLa signal. 
 
Figure 13.2. PKCƞ detection on a membrane transferred from a 15%gel. 1. Candida alb. treated 
with MPER, 2. Candida alb. treated with Chilov, 3. Candida alb. treated with MPER and Chilov, 4. 
Second Candida alb. culture treated with MPER, 5. Second Candida alb. culture treated with Chilov, 
6. Second Candida alb. culture treated with Chilov and MPER, 7. HeLa treated with MPER, 8. HeLa 
treated with Chilov, 9. HeLa treated with MPER and Chilov 
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The percentage of the acrylamid gel had been increased from 12% to 15%. So this change had 
visible effects on our result. The last time two bands of Candida were visible whereas this 
picture showed only one signal for Candida at 50kDa. The HeLa spots were similar to the last 
gel. They could be found at approxiametly 100kDa, always above the Candida albicans’ 
signal. Unlike the last time PKCƞ already delivered a visible signal during the first minutes. 
The picture shows very clear, that with MPER/Chilov and even MPER alone, the signal was 
enhanced. 
 
 
 
Figure 13.3. PKCƞ detection after the classic transfer. 1. Candida alb. treated with MPER, 2. 
Candida alb. treated with PMA250 (inactivated), 3. HeLa treated with MPER  
 
The picture above shows the membrane which was obtained after the classic transfer from a 
12% gel. The semidry transfer had been replaced by the classic transfer regarding to enhance  
the expression of the spots. Unlike the results of the semidry transfer, the spots were now 
stronger expressed. Yet the characteristics of the PKCƞ signals differed from the signals 
obtained after the semidry transfer of a 12% gel.  The Candida spots were expressed at 70kDa 
and 100kDa not at 50kDa. While the HeLa signal was usually above the Candida signal, this 
picture shows an inverse situation. Summing up, the modification of the transfer leads to a 
change in detection. 
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Figure 13.4. PKCƞ detection after the classic transfer from a 15% acrylamide gel. 1. Candida alb. 
treated with MPER, 2. Candida alb. treated with PMA250 (inactivated ), 3. HeLa treated with MPER   
 
In this experiment the percentage of the acrylamide composition was increased from 12% to 
15%. Even though references preferred a 12% acrylamide gel, the aim was to see Histones 
(17kDa) and PKCƞ on the same gel. The higher percentage should avoid the running out of 
the small proteins during the gel migration. However the results indicated an amelioration of 
our working parameters. The spots resembled a smile, which pointed out to too hot or too fast 
migration. In fact, the migration of a 15% gel heated the whole tank due to a stronger 
resistance, which occured as soon as a higher percentage of acrylamide was chosen. 
 
Figure 13.5. PKCƞ detection after transfer of a 12%gel and after transfer of a 15%gel. 1. Candida 
alb. treated with MPER, 2. Canida alb. treated with PMA250 (inactivated) 3. HeLa treated with 
MPER 
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PKCƞ was on this picture transferred from a 12% acrylamide gel. There was a strong 
difference between the classic and semidry transfer. While the semidry transfer didn’t result 
in any signal, the classic transfer made more than a spot visible. The modification of the 
transfer method should lead to an optimized detection, as the suspicion rised up that the 
semidry transfer wasn’t the best solution of transferring the proteins to the membrane. The 
two different methods compared, the semidry version led to less detection. 
The difference between the classic and semidry transfer had also been studied using a 15% 
gel. The result didn’t differ from those of the 12% gel, since the semidry transfer also didn’t 
result in any spots. The signals were strong, at the first regard very unspecific, but three spots 
stood out from the others as they were stronger expressed. The spots at 100kDa, 70kDa and 
50kDa could be related to those of the PKCƞ.  
We tried out different percentages of acrylamide to see the difference in the way of detection. 
As the high molecular proteins were more likely to be detected with a low percentage of 
acrylamide gel than the low molecular proteins with a high percentage gel, we decided to 
combine two different percentages. The mixing up of two different percentages could be 
carried out by preparing a gradient gel.  
Actually we had a higher resolution using a 
gradient gel. The PKCƞ signal was detected in 
evidence. Thereby the quantities of dots could 
be distinguished at different kDa levels. As 
already detected the majors spots were at 
100kDa, 70kDa and 50kDa. So the gradient gel 
resulted finally in a very clear image. 
 
 
 
 
 
 
 
Figure 13.6. PKCƞ detection on a gradient gel using a Candida albicans culture 
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The Histones H3 had been detected successfully at 
17kDa. A 15% gel was used to reach a higher 
expression of the Histones. In this experiment the 
transfer conditions were changed, then the membrane 
was kept overnight at 5V. The Histones act as 
references for the quantity measurement. They should 
give an idea for the intensity in which the proteins of 
interest are detected. 
 
That’s why we decided to use a gradient gel as we wanted to detect the proteins of interest 
and Histones on the same membrane after stripping.  
 
3.12.2   Making Hsp90 visible 
 
 
Figure 13.8. Hsp90 lightning on 12% gel. 1. Candida alb. treated with M-PER, 2. Canida alb. treated 
with Chilov, 3. Candida alb. treated with M-PER and Chilov, 4. Second Candida alb. culture treated 
with M-PER, 5. Second Candida alb. culture treated with Chilov, 6. Second Candida alb. culture 
treated with Chilov and M-PER, 7. HeLa treated with M-PER, 8. HeLa treated with Chilov, 9. HeLa 
treated with M-PER and Chilov 
 
This time the transfer was carried out in a semidry manner from a 12% acrylamide gel. The 
revelation showed many spots differing in their intensity. The signal from the human HeLa 
cells distinguished in their strongness from the other dots while the Candida albicans’ cells 
expressed two dots, one at 90kDa at the same kDa level as the HeLa signal, and the others 
 
Figure 13.7. Histones H3 1. 
Candida alb. treated with M-PER, 2. 
Candida alb. treated with PMA250 
(inactivated) 3. HeLa treated with M-
PER 
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much lower at 50kDa. This effect could be caused by the primary antibody, which detects 
endogenous levels of the total Hsp90 protein.  
References explain the effect of the fragment at 47kDa as the result of the protease ycaB, 
which is typical in Candida albicans. The eliciting antigen appears to be part of the C-
terminal portion of Candida albicans Hsp90 [21]. 
 
3.12.3   Femtoluminescence detects Gsk3α 
 
 
Figure 13.9. GSK3α detected on a 12%gel. 1. Candida alb .treated with M-PER, 2. Candida alb. 
treated with Chilov, 3. Candida alb. treated with M-PER and Chilov, 4. Second Candida alb. culture 
treated with M-PER, 5. Second Candida alb. culture treated with Chilov, 6. Second Candida alb. 
culture. treated with Chilov and M-PER, 7. HeLa treated with M-PER, 8. HeLa treated with Chilov, 9. 
HeLa treated with M-PER and Chilov 
 
The protein GSK3α was very difficult to detect, because its concentration was too low to give 
an adequate signal with picoluminescence. So the idea occurred to reveal the membrane under 
femtoluminescence. This method was sensible enough to make the dots of GSK3α visible.
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3.13   Discussion 
 
Western blotting had offered us the possibility to get an insight in the protein world of 
Candida albicans. To get the best resolution, many difficulties had been resolved.  
One obstacle presented the detection of small molecules on one gel. As the semidry transfer 
was used as the unique possibility to drive proteins out of the gel and on the membrane at the 
beginning, the small molecules (e.g. Histones) weren’t recovered. It is well known that under 
semidry electro transfer conditions some low molecular weight proteins are driven through 
the membranes. So they got lost on the way, finally ending up in no detection. With the 
change of the transfer method, the small proteins had been rescued. Through the classic 
transfer you can see the proteins of interest. Furthermore, the spots of PKC and Hsp90 
proteins were enhanced, being stronger detected with this classical transfer method. The 
modification of the transfer led to a change in detection, modifying the number of spots. 
So the transfer problem was solved. As the low weight molecules were detectable, the 
problem occured to see both, high weight molecules and low weight molecules on one gel. 
Thus the stripping method was brought in to solve this problem. The stripping solution 
facilitated the detection of the proteins on the same gel but not at the same time.  
The highest possible resolution was targeted, what was finally realized with the gradient gel.  
So there wasn’t any obstacle remaining to step forward to the essential work with the affinity 
micro assay.  
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4 Affinity micro assay 
 
The affinity micro assay uses the principles of an affinity chromatography; but in smaller 
dimension. As an efficient proteomic approach it allows to discover the true selectivity of an 
inhibitor. The small quantities which are required for the in vitro experiment render him 
attractive as a preparative method for the affinity chromatography. It concentrates its action 
only on the proteins of interest. 
 
4.1 Technique [8]  
 
Like the affinity chromatography it uses the reversible interaction between a protein and a 
specific ligand coupled to a chromatography matrix. The technique scores with high 
selectivity for the proteins of interest. 
It is unique in purification technology since it is the only technique that enhances the 
purification of a molecule on the basis of its biological function or individual chemical 
structure. The technique affords the separation of active biomolecules from denaturized or 
functionally different forms, the isolation of pure substances at low 
concentration in large volumes of samples and also the removal of 
specific contaminants. 
Successful affinity purification uses a biospecific ligand that can be 
covalently attached to a chromatography matrix. The coupled ligand 
has to retain its specific binding affinity for the target molecules and, 
after washing away unbound material, the binding between the ligand 
and target molecule has to be reversible to allow the target molecules to 
be removed in an active form. Any component can be used as ligand to 
purify its respective binding partner.  
We worked with the typical biological interaction between an antibody 
and antigen. 
Figure 14. Affinity chromatography [GE HEALTHCARE, 2007] 
 
Ligand 
Protein 
 
Sepharose 6B 
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The affinity between ligand and target molecule is supposed to be a result of electrostatic or 
hydrophobic interactions, van der Waals‘forces and/or hydrogen bonding. To elute the target 
molecule from the affinity medium this interaction can be reversed, either specifically using a 
competitive ligand, or none specifically, by changing the pH, ionic strength or polarity.  
 
4.1.1 The choice of matrix, ligand and coupling method [47] 
 
In general the matrix should be chemically and physically inert. The particle size and porosity 
are designed to maximize the surface area available for coupling a ligand. 
Sepharose provides a macroporus matrix with high chemical and physical stability and low 
non-specific adsorption to facilitate a high binding capacity and sample recovery and to 
ensure resistance to potentially harsh elution and washing conditions. The choice of a 
preactivated Sepharose matrix depends on the functional groups available on the ligand and 
whether a spacer arm is required. 
 
 
 
Figure 15. Epoxy activated Sepharose 6B [GE HEALTHCARE, 2007] 
 
To avoid steric interference, a spacer arm is introduced between the matrix and the ligand. 
The binding site of a target protein is often located deep within the molecule, so that it has no 
access to the binding site. In this case the spacer arm should ameliorate the effective binding. 
The length plays thereby an important role because if it is too short, the arm is ineffective and 
the ligand fails to bind the substance. But if it is too long, the nonspecific binding of the 
proteins is enabled and in series the selectivity of the separation is reduced.  
 
Spacer arm 
Affinity micro assay 
 
 
50 
 
  
 
 
Figure 16. Spacer arm [GE HEALTHCARE, 2007] 
 
In our case the Sepharose reacts with the epoxy group of the 12 atoms spacer arm and creates 
so a linkage to the hydrophilic group which is suitable for the immobilization of the ligand.  
The ligand must selectively and reversibly interact with the target molecule and must be 
compatible with the anticipated binding and elution conditions. It must carry chemically 
modifiable functional groups through which it can be attached to the matrix without loss of 
activity. Too high affinity will result in low yields since the target molecule may not 
dissociate from the ligand during elution. In our experiment we worked with BisIII. 
Ligands are coupled via reactive functional groups such as amino, carboxyl, hydroxyl, thiol 
and aldehyde moieties. The ligand should be coupled through the least critical region of the 
ligand to minimize interference with the normal binding reaction. 
 
 
 
 
 
 
Sepharose  
Coupling via an 
amino group 
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4.1.2 Kinetic in affinity chromatography 
 
The binding adsorption and desorption of a target protein to and from an affinity ligand can be 
considered involved in terms of the binding equilibria and the kinetics of adsorption and 
desorption.  
 
 
Figure 17. Kinetic [GE HEALTHCARE, 2007] 
 
C...concentration of free competing ligand 
T...concentration of free target 
CT…concentration of the competing ligand/target complex 
 
If the competitive ligand isn’t very effective in capturing the target protein, the concentration 
of the competiting ligand has to be increased. 
Agents that weaken the interactions between the ligand and the protein are expected to 
function as efficient eluting agents such as ATP for kinase. The eluting agents compete for 
binding to the target protein.  
4.2 Materials 
 Centrifuge 5417C/R, Eppendorf 
 Rotator RO1, APELEX 
 Mini lab Roller Rotatorie, Labnet 
 VIVASPIN 500, Sartorius Stedium- biotech 
 Shaking Incubator SI500, Stuart 
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 96 well-plate, Sterile Nuclon Surface 
 DensiCHECKTM plus, bio-Merieux 
 
4.3 Working Conditions 
 
4.3.1 Preparing the matrix 
 
The epoxy-activated sepharose 6B must be first of all washed at neutral pH before coupling 
the ligand. To ensure the reproducibility of the affinity micro assay, we always initiated the 
experiment with the same quantity of sepharose.  
4,28mg freeze dried epoxy-activated sepharose were weighted in 2ml Eppendorf tube each for 
the matrix and the control matrix to be afterwards washed with water. About 1ml water was 
added to the samples and mixed manually for 5 minutes before 1min centrifugation at 
2000rpm at room temperature. The supernatant was removed while the obtained pellet was 
kept. This procedure was repeated for an hour whereas the medium began to swell. 
 
4.3.2 Coupling the ligand 
 
To obtain a concentration of 0,1M for the bisindolylmaleimides, 17mg BisIII should be 
directly dissolved in the coupling solution containing 200µl 50% DMF and 200µl 0,2M 
Na2CO3. Then 100µl sepharose 6B were mixed with 100   prepared BisIII. Thereby we 
watched out to keep one matrix as our control, which wasn’t coupled to the ligand. The 
coupling was now carried out by adding 10mM NaOH while incubating overnight on a 
rotating wheel at 30°C. 
 
4.3.3 Blocking active groups 
 
The next day the ligand excess was washed away using the coupling buffer. Any remaining 
active group was blocked by incubating in 1M ethanolamine ph=8 where it stayed for at least 
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one day at a temperature between 40°C and 50°C. The active groups of the control matrix 
should also be inactivated in this step. 
To ensure that there was still no active group, the matrixes were washed with four cycles of 
altering pH. One cycle was performed with an acid solution
12
 while in next cycle the solution 
was replaced by a basic
13
 one. Thereby we worked with caution to keep the pellets after 
centrifugation at 2000rpm at room temperature. 
 
4.3.4 Protein Association 
 
Before the association could take place, proteins should be prepared in binding buffer
14
. We 
mixed 100µl matrix with 50µg of our protein extract and let the solution
14
 incubate 3h at 4°C 
on a rotating scroller. Afterwards the samples were centrifuged to obtain the supernatant 
which were studied later by western blotting or dot blotting.  
Four washing runs with strong and less strong concentration of NaCl
15
 were carried out 
thereby working on ice. The supernatant was always poored away after centrifugation at 
2000rpm for one minute. 
 
4.3.5 Elution 
 
After several different attempts to elute the protein of interest, we choose the competitive 
elution as the most efficient method. In the process a step elution was proceeded using 10mM 
BisIII and 10mM ATP as a competitor. The samples were each incubated for 15min in the 
elution solution (100µl), the supernatants were collected after centrifugation at 2000rpm for 1 
minute and a second elution using the same parameters was performed.  
 
4.3.6 Western Blotting 
 
The supernatants and eluates, which were collected in the course of the in vitro 
association, were concentrated via viva spin. They were centrifuged with 
15000rcf and so concentrated to a volume of 30 µl. 
 
Figure 18. Viva Spin 
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They were prepared for deposing on the gel after this schema: 
 
 
The migration last 2 hours at 100V that followed by the classic transfer at 25V for 2h30min. 
Membranes were incubated with the primary antibody PKCƞ overnight at 4°C and with the 
secondary antibody (1h at room temperature) before detecting the signal with 
picoluminescence. 
  
4.3.7 Dot Blot 
 
The eluates and supernatants were concentrated via vivaspin and mixed up with LB4X before 
denaturating at 95°C. The samples were then ready to be applied on the nitrocellulose 
membrane. We used a pipette to add 5µl after 5µl to form small dots of our samples. The 
dried membrane was blocked with milk for 30min and then incubated with the primary 
antibody overnight at 4°C. After incubation with the secondary antibody for one hour at room 
temperature, the spots on the membrane could be detected.  
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4.3.8 Immuno –Fluorescence 
This time our interest was directed to the matrix with the ligand after we had eluted the 
proteins. After blocking in BSA/TBST for 39min at room temperature, we incubated the 
matrix with the primary antibody (1:500 dilution in BSA/PBST) for an hour at 37°C while 
agitating. Afterwards the matrixes were washed with PBST (0,05%Tween). Then they were 
incubated with the secondary antibody for an hour at 37°C and washed again with PBST. 
Finally they were incubated with TMB for 15min at room temperature, protected from light. 
We could already remark a coloration after a few minutes. After centrifugation at 2000rpm we 
kept the supernatant to read the optical density at 450nm.  
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4.4 Results-Affinity micro assay 
 
After the proteins in Candida albicans have been validated, the task was to see an interaction 
between the synthesized bisindolymaleimideIII and the PKCƞ of the fungal pathogen. As the 
affinity micro assay was already successfully documented with the human carcinogen cells 
(HeLa), first of all the experiment was reproduced with the given parameters. But the results 
were not as expected thus a few parameters of the protocol have been changed. The quantity 
of the matrix has been augmented to enhance the amount of interaction between the ligand 
and the proteins. To test the quality of the elution, different types have been tried. The 
competitive elution seemed the most efficient method compared to the way of elution with the 
Laemmli buffer
16
. The result was a very weak signal but still not satisfying. Later, the control 
matrix, which shouldn’t give any signal, delivered the same signal as the sample of interest. 
So, the interest was focused on blocking the remaining groups, because they were supposed to 
cause an unspecific signal. Therefore the incubation with ethanolamine was carried out which 
had finally a visible effect on the results. The unspecific signal was minimized but not fully 
eliminated. The little noise, that stayed, was insignificant because the signal of the sample 
showed a much higher intensity. To increase the intensity, a longer association time was 
initiated with the protein, ending up in an inverse effect which is possibly regarding the 
kinetics. The balance went from one side to the starting position again. After this reflexion the 
association time was again reduced. At the same time we changed the mode of elution. The 
step elution was introduced and after adding ATP, which is known as the natural ligand of 
protein kinase, the expected signal in Candida albicans was noticeable.  
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1. Candida albicans (reference),2. Eluat Control,3. Eluat Sample,4. Supernatant Control, 5. 
Supernatant Sample 
 
For the first time an evidence was established that there must be an interaction between PKCƞ 
and BisIII in Candida albicans, validating the hypothesis of an action of this ligand through 
its interaction with PKC.  
 
 
 
 
  
 
 
1.Supernatant Control, 2. Supernatant Sample, 3. Eluat Control, 4. Eluat Sample ,5. Candida albicans 
reference 
             1                                  2                          3                             4                       5 
     2                                                                        3 
1                           2                             3                             4                              5 
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The dot blot of Candida albicans is another proof that there is an interaction between the 
ligand and our protein of interest. The concentration of the control supernatant is observably 
higher than the concentration of the supernatant of the sample. This also shows that there 
must be some proteins linked to the ligand. But the suspect remained that we didn’t manage to 
elute the whole amount of proteins. This fact wanted to be attested with an immune reaction. 
The affinity micro assay was performed with the usual parameters. To prove that the proteins 
last coupled to the ligand, the proteins were eluted and tested on the remaining matrix. 
Therefore an antibody was attached, which was specific for the protein of interest. It has been 
revealed with the help of a fluorescent substrate at 450nm.  
 
 
 
The eluates of the samples HeLa and Candida albicans were visibly colorated, which 
indicated that there was PKCƞ. The control matrixes in contrast were clear. Indeed, a 
considerable amount of PKCƞ remained attached to the matrix like suspected.  
The proof was delivered that there is an interaction between the ligand and PKCƞ. But the 
elution parameters need to be improved and so the interaction between the ligand and other 
proteins of Candida albicans (i.g. Hsp90, GSK3) has to be studied more exactly before 
stepping forward to the affinity chromatography. 
 
 
HeLa                     Candida 
Control Matrix 
Sample Matrix 
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5 Conclusion & Perspectives 
 
As soon as the normal body balance is disturbed, the natural inhabitant Candida albicans can 
turn to an invasive infection. The candiasis infestation is located mainly in the intestinal and 
mucutaneous system, but known to affect many parts of the human body. The exposure to all 
common modern conditions like antibiotics or steroids, oral contraceptives, overly-acidic pH 
levels from poor diet and stress, hormone imbalances and exposure to environmental toxins 
sets our bodies up for the fall into fungal yeast growth. Then the harmful fungal overwhelms 
the beneficial flora of an immunocompromised individual. It is called “opportunistic” fungus, 
using the opportunity to colonize all tissues in an uncontrolled way. Large numbers of this 
germ can weaken the immune system since Candida albicans wants to gain control over this 
system. 
Once infected with candiasis, it can cause a wide spectrum of clinical syndroms. So the 
treatment varies depending on the anatomic location of the fungal pathogen. The therapy 
includes azoles, allylamines, polyens, which interfere with the ergosterol biosynthesis. 
Furthermore the antifungal treatment creates stress responses, which activate a wide range of 
signaling pathways. Key regulators of these pathways are involved in the development of a 
remarkable resistance. Their contribution to establish a persistent resistance presents a serious 
threat for the human health, since the antifungal handling loses their efficacy due to the 
potency of Candida albicans to develop an effective method to get invulnerable to the 
conventional therapy in a short term.  
So the decision was made to validate the proteins which are assumed to be responsible for the 
defence scaffold of Candida albicans. First of all the different amounts of protein expression 
were quantified, known to play an important role in the transduction network. Therefore   the 
work focused on the key regulators PKC, Hsp90 and GSK3. It could be proofed that they are 
all in a considerable amount in Candida albicans. But their participation to the resistance has 
not been exactly researched yet. PKCƞ was chosen for further experiments, because it 
emerged in the majority of western blots as the strongest expressed protein in comparison to 
GSK3 and Hsp90. 
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The bisindolylmaleimides are well known inhibitors of PKC in mammalian cells. They are 
assumed to interfere with the PKC signaling pathway. An investigation with the affinity micro 
assay seemed to be reasonable to resolve the question if BisIII is also a potent inhibitor of 
PKC in Candida albicans.  
For the first time an interaction between PKC and BisIII could be observed. Thus this protein 
could be utilized as a target to restore the sensibility of Candida albicans to the azoles. It has 
not been elucidated yet if there are also interactions with Hsp90 and GSK3.  
Nevertheless this work is an approach for more detailed studies with the affinity 
chromatography and mass spectrometry, where the whole repertoire of interactions can be 
described and so used as an essential and novel step in the antifungal treatment.  
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